Deals this week: EpimAb Biotherapeutics, Biohaven Pharmaceutical, Zai Lab (Shanghai)

Chinese-based biopharmaceutical company EpimAb Biotherapeutics has completed a series A venture financing round to raise funds required to advance its proprietary bispecific platform technology and develop a pipeline of candidates in immuno-oncology …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news